Geron Corp. (GERN)
1.88
-0.04
(-2.08%)
USD |
NASDAQ |
Feb 20, 16:00
1.85
-0.03
(-1.60%)
After-Hours: 20:00
Geron Research and Development Expense (Quarterly) : 21.07M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.436M |
| Insmed, Inc. | 254.91M |
| SELLAS Life Sciences Group, Inc. | 4.216M |
| Rezolute, Inc. | 14.35M |
| GT Biopharma, Inc. | 0.634M |